There is now a substantial amount of data available on all aspects of peripheral arterial disease, including both incidence and prevalence, associated risk factors, and the natural history of the disease. Peripheral arterial disease is a significant cause of morbidity in the community, especially in the elderly, and therefore a knowledge of its aetiology and natural history is important both in terms of planning health care services, and in enhancing our understanding of disease in the coronary and cerebral arteries.
Incidence and prevalence
The presence of peripheral arterial disease in the general population has been assessed in two ways, either by a symptom enquiry to elicit a history of intermittent claudication, or by a physiological test to estimate the blood supply to the lower limb. The first approach is quick and easy and has therefore been widely used, but as it measures only symptomatic disease it is inevitably an underestimate of the prevalence of peripheral atherosclerosis.
Symptomatic disease
Intermittent claudication is the prime symptom of lower limb ischaemia, and its prevalence in the general population therefore represents a useful indicator of the degree of morbidity due to peripheral arterial disease. As most claudicants are currently not referred to hospital unless they have symptoms sufficiently severe to warrant surgery, an accurate estimation of the prevalence of intermittent claudication can be acquired only from a population survey. In 1962, Professor G Rose at the London School of Hygiene devised an intermittent claudication questionnaire to aid the diagnosis of peripheral arterial disease in epidemiological surveys"; this was subsequently adopted by the World Health Organization (WHO) and has since been used throughout the world. Unfortunately, although the questionnaire is known to be very specific, it is only moderately sensitive.s-? but until a more accurate alternative is adopted," it remains the most valid way of making international comparisons of the prevalence of intermittent claudication. Figure 1 illustrates international differences in the prevalence of intermittent claudication determined using the WHO/Rose questionnaire, in samples of middleaged men selected from the general population. The degree of variation is clearly large, from 0,9% in North America'? to 6.9% in MOSCOW 15 ; some of this reflects true international differences, but unfortunately none of these studies is strictly comparable because of different age structures in the populations, possible errors of translation and healthy worker effects. However, it is probably true to say that there is an increase in intermittent claudication with age, 6,14.17,18 and that it is more common in men than in women. 4,14.19-21 The other main symptom of peripheral arterial disease is rest pain, indicating critical limb ischaemia. The prevalence of rest pain has not been determined in any population surveys, possibly because it is difficult to diagnose simply by questionnaire as the symptoms are difficult to define and easily confused with other causes of leg pain, such as arthritis and venous disease. However, as the majority of patients with critical ischaemia are referred to hospital for treatment, fairly complete data can be obtained from hospital records. From the number of major amputations, it can be estimated that the incidence of critical limb ischaemia ranges from 500 to 1000 per million population per year. This takes into account that a considerable number of patients die prior to amputation, and that the majority of patients benefit from reconstructive surgery.P
Asymptomatic disease
To detect milder grades of peripheral atherosclerosis that are not yet producing symptoms, several large-scale population surveys have also included simple noninvasive tests. The most widely used test has been the measurement of ankle systolic pressures,4,6,1l but the Basle study also included analysis of pulse waveforms detected on oscillography.P and a recent study in the USA included arterial waveforms and a reactive hyperaemia test. 11 The most sophisticated non-invasive screening has been the inclusion ofBmode ultrasound scanning of the popliteal artery in the ARIC Study." Unfortunately, because there is currently a lack of standardization between different surveys it is impossible to make true comparisons, but in general the prevalence of disease detected by noninvasive procedures is about three times greater than the prevalence of intermittent claudication, with a similar distribution by age and sex.
More accurate documentation of the extent of asymptomatic disease in the population can be obtained from autopsy studies. In the 1960s, a study of 293 unselected adult autopsy cases carried out in Oxford found that 15% of men and 5% of women had disease severe enough to produce more than 50% stenosis of at least one artery. More surprisingly, none of the men and only one of the women were completely free of atherosclerotic plaques in their common iliac arteries.>' Similar results have also been found in autopsy studies in Pittsburgh.P and Malmo, Sweden.w
Aetiology
Factors associated with the development of peripheral arterial disease have been identified in numerous cross-sectional surveys and casecontrol studies, but conclusive evidence regarding the role of individual risk factors requires longterm follow-up studies of large cohorts of the general population. Unfortunately, there have been relatively few cohort studies performed to date, but the available evidence suggests that cigarette smoking, hyperlipidaemia and hypertension are particularly important. The evidence supporting the roles of individual risk factors in the development of atherosclerosis will be discussed individually.
Smoking
A recent report published by the US Surgeon General states that 'cigarette smoking is the single most powerful risk factor for peripheral vascular disease' .27 Indeed, cross-sectional surveys of the general population suggest that the relative risks of smoking in relation to developing peripheral arterial disease range from 1.4 15 to more than tenfold. 2M This variation can be accounted for partly by differences in age, sex and nationality of the study population, and by the criteria used to define a smoker and the presence of arterial disease. Multivariate analyses suggest that smoking has an independent effect greater than other risk factors, 1 ,4,2'1 and it also appears to be a
Study location and author
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The extent to which smoking contributes to the development of disease has also been calculated from cross-sectional studies, where current smoking appears to contribute to between 14% and 53% of disease-I; if ex-smokers are also included the figures become even higher. 3.12.14.211,2I,32 In the Framingham Study, 16 years of follow -up suggested that 7X% of cases of intermittent claudication could be attributable to smoking. 1 Substantial risks are therefore associated with smoking, but the accuracy of some estimates must be questioned as under-reporting of smoking undoubtedly occurs.
Blood pressure
Elevated blood pressure has been associated with the development of peripheral arterial disease in both case-control studies and crosssectional surveys. In general, the findings support In contrast, a Danish study found significant correlations between initial systolic and diastolic pressures and the ankle pressure index after 10 years,e whilst the Basle Study did not find systolic pressure to be independently related to the development of intermittent claudication.Z? Therefore the importance of elevated blood pressure as a risk factor for arterial disease has not been clearly established, and may in fact be secondary to the disease.
Lipids
Numerous clinical and epidemiological studies have examined the role of serum cholesterol, triglyceride and lipoproteins in the aetiology of peripheral arterial disease, and more recently essential fatty acids and anti-oxidants have also been studied as potential risk factors. In general, high lipid levels occur more commonly in the elderly.w in diabetics.t? and in obese subjects.l" but the specific roles of each lipid will be discussed in more detail.
Triglycerides
Numerous hospital-based case-control studies have identified elevated levels of serum triglycerides in patients with peripheral arterial disease ( Figure 2) . Similarly, the majority of cross-sectional surveys carried out in the general population have also shown a univariate association with triglyceride levels,4,6,lO,18,21 but others have shown no significant relationship.ll,14,46,47 However, when multivariate analyses are performed to adjust for the influence of other risk factors, including other lipids, no independent relationship can be found between triglycerides and the occurrence of peripheral arterial disease, 4,6,10 The longitudinal relationship between serum triglyceride and the future development of peripheral arterial disease has been examined in the Basle Study48 and in the Glostrup Study." Of 2759 men in the Basle Study, 174 developed disease during a five-year period, and of these 59% had elevated baseline levels of triglyceride (p <0.001). In the Glostrup Study, the fasting serum triglyceride level at 50 years of age was correlated with the ankle:brachial pressure index 10 years later (p <0.05). However, again this relationship disappeared on multivariate analysis adjusting for smoking, blood pressure and serum cholesterol. Recent evidence from the Edinburgh Artery Study suggests that the strong univariate relationship between triglyceride and arterial disease can mostly be explained by the correlation between triglyceride and non-HDL cholesterol. 6 Therefore current evidence would indicate that the relationship of triglycerides with peripheral arterial disease is comparable to that with ischaemic heart disease: a strong univariate association disappearing on multivariate analysis.
Cholesterol
Elevated levels of serum cholesterol in patients with peripheral arterial disease have also been identified in the majority of hospital-based case-control studies ( Figure 3 ), but significantly elevated levels have not been found in all studies, particularly in those where the age-sex matching was poor,50,51 Similarly, although most cross-sectional studies in the community show elevated cholesterol levels in diseased subjects,4,6,l1,14,52 a few have shown no relationship.lO,12,21 In the Edinburgh" and Dunedin-" cross-sectional studies, the relationship with serum cholesterol persisted after adjustment for other risk factors, but this was not the case in the Israeli Study.i! However, positive associations between serum cholesterol and the development of peripheral arterial disease have been found in two longitudinal studies: after 26 years of follow-up in the Framingham Study, serum cholesterol was found to be a significant, but weak, risk factor for intermittent claudi-cations>; after 10 years of follow-up in the Danish Study, serum cholesterol at 50 years was found to correlate with ankle:brachial pressure indices, and this was independent of other risk factors.s Therefore, on balance, there is sufficient evidence to indicate that elevated cholesterol levels are an independent risk factor for the development of peripheral arterial disease, However, in recent years interest in the role 
Apolipoproteins
Each LDL particle contains one molecule of apoli~oproteinB (apo B), and a small proportion also includes another equally large protein, apolipoprotein (a), which is chemically linked to apo B, This subfraction of LDL is known as lipoprotein (a), and has been identified in much larger concentrations in those with a family history of early onset coronary heart disease, and it is also an independent risk factor for myocardial infarction or coronary death.w However, there is little, if any, research on this lipoprotein in peripheral arterial disease. Apolipoprotein B levels are also related to the occurrence of coronary heart disease.v! and there is some evidence to suggest that the same holds true for peripheral arterial disease. In a case-control study of 88 male subjects, Pilger et al.»? found that those with peripheral atherosclerosis had significantly higher levels of apo B than the controls (p <0.001), and in a larger study of 205 patients there were significant differences in the apo B gene locus in patients compared with the healthy population.P Indeed, it has been suggested that apolipoproteins may be a better discriminator between cases of peripheral arterial disease and normal subjects than either lipid or lipoprotein levels.>?
Essential fatty acids and anti-oxidants Essential fatty acids are derived from two parent molecules, linoleic acid (C18:3, n -6) and alphalinolenic acid (C18:3, n -3). Deficiencies of linoleic acid were first noted in plasma cholesterol esters of patients with coronary, aortic and peripheral vascular disease in 1969 by Kingsbury et al. 63 Subsequent studies have shown that low levels of linoleic acid are associated with an increased risk of developing coronary heart disease,64-66 and throughout Europe low levels of linoleic acid are known to be inversely related to the gradient of coronary heart disease.s? In Scotland , men with coronary heart disease have lower than expected levels of adipose linoleic acid,66 which represents a risk independent of the classical factors associated with disease.w There is some evidence that arachidonic acid (C20:4 , n Author -6) and eicosapentaenoic acid (CZO:5 , n -3) levels are also lower in those with coronary heart disease. 65 ,68 However, there have been few , if any, studies examining the role of essential fatty acids in peripheral arterial disease.
Recently, naturally occurring anti-oxidants, particularly vitamins E and A, have also been shown to be deficient in patients with coronary and peripheral arterial disease. 69 ,7o The presence of anti-oxidants protects polyunsaturated fatty acids from peroxidation, and lipid peroxides have been known for many years to be correlated with the severity of aortic atherosclerosis.Z! In one recent study, plasma lipid peroxide levels were found to be significantly higher in cases of both peripheral arterial disease and ischaemic heart disease than in control patients.P Therefore a deficiency of anti-oxidants may promote the development of atherosclerosis both by reducing the levels of essential fatty acids and by promoting the formation of lipid peroxides .
Haemostatlc factors
Recent studies have examined the association between various haemostatic factors and the presence of peripheral arterial disease. Fibrinogen concentration in the blood is believed to be a particularly important factor in the development of atherosclerosis, as high plasma levels have been identified in subjects with intermittent claudication in numerous case-control studies. 55, [73] [74] [75] [76] [77] [78] [79] [80] In population surveys, cigarette smoking has been related to elevated fibrinogen concentrations,81-86 and after smoking cessation the concentration falls. 14 Other factors that may influence fibrinogen levels include age, obesity, social class, serum cholesterol, diabetes mellitus, intake of cereal fibre, alcohol consumption, use of oral contraceptives and the menopause.81,82,84-89 Recent evidence from the Edinburgh Artery Study also shows an increased risk of peripheral atherosclerosis due to variation at the beta-fibrinogen locus.?" Blood viscosity has also been found to be higher in cases of intermittent claudication than in control subjects,74,50.75,76,91 and some studies have identified a similar association with elevated haematocrit,1l,73,74,75,92 although after 26 years follow-up in the Framingham Study a raised haematocrit was not associated with a greater risk of intermittent claudication." Diseased subjects also have an increased fibrinogen lysis time,93 decreased fibrinolytic activity.S' raised levels of Factor VIII ,73,79 Factor XIII,94 plasminogen'> and antiplasmin."? No significant differences in antithrombin III have been dernonstrated.P Alterations in platelet function have also been identified, including low platelet counts.?" increased platelet aggregability'" and decreased platelet survival time,96 although others have not identified any significant changes.P-?e Betathromboglobulin, a marker of platelet release, is also elevated.P" Serum uric acid, which may increase platelet aggregability.?? has been identified at higher levels in cases of peripheral arterial disease than in controls,22,41,98 but this was not confirmed in the Danish longitudinal study." These results all suggest that patients with peripheral atherosclerosis have an increased thrombotic tendency, but the mechanism through which the various haemostatic factors may contribute to chronic vessel wall pathology is unclear.
Glucose intolerance
Peripheral vascular disease is a well-known complication of diabetes mellitus.>? In a general population-based Finnish study of subjects The epidemiology ofperipheral arterial disease 11 aged 3D-59 years, the age-adjusted prevalence of intermittent claudication was 3.4 times higher in diabetic men, and 5.7 times higher in diabetic women.l" However, another Finnish study found no significant difference between the prevalence of claudication in newly diagnosed subjects with non-insulin-dependent diabetes compared with control subjects; however, after a five-year follow-up period, the age-adjusted incidence of intermittent claudication was significantly higher in diabetics than in nondiabetics.v? After five years' follow-up of male civil servants in the Israeli Ischaemic Heart Study, the incidence rates of claudication doubled in both those with previously diagnosed diabetes and those identified by impaired glucose tolerance in the survey.100 After 20 years' follow-up in the Framingham Study, the age-adjusted incidence rates for men were 12.6 per 1000 person years for diabetics, and 3.3 for nondiabetics, and every indicator of impaired glucose tolerance was associated with increased risk. 35 As might have been expected, the Aachen Study'? and a cross-sectional study in Moscow and Berlin-? found glucose tolerance to be impaired more commonly in individuals with intermittent claudication. However, there are a surprising number of epidemiological surveys which do not clearly implicate glucose intolerance as a risk factor in the general population. Community studies in Oxford,21 Finland'< and Jerusalem!' found that the prevalence of intermittent claudication was not related either to a high fasting blood glucose, or to blood glucose following an 'oral glucose load', and the Basle Study actually found an inverse association between the degree of glucose tolerance and the occurrence of disease.s? Both the Basle-? and Danish-longitudinal studies have also produced conflicting results. Thus, despite the findings of the Framingham Study, the evidence overall does not clearly implicate glucose intolerance in the general population as a risk factor for peripheral arterial disease.
Other risk factors
The association between personality and risk of developing coronary heart disease has been the subject of much research, but relatively little work has been carried out into its relation with peripheral arterial disease. In one small study of 26 claudicants and 13 control subjects there were no significant differences betwe~n typep ersonality scores, although thos~~Ith claudication had more type A characteristics, and the responses to ange.r-relat~d questio~s s~ggested that patients with interrmttent claudication were poor at controlling expressions ?f anger.101. In the Edinburgh Artery Study, a hostile personality was found to be related to both asymptomatic and symptomatic disease, suggesting that hostility is a risk factor for atherogenesis rather than simply a response to atherogenesis (Fowkes et al., 1991, unpublished data) . A recent review of personality type in relation to disease concluded that those with type A personality were more at~isk of developing both cerebrovascular and penpheral vascular disease, but did not have an increased risk of incurring other illnesses.l'P In the Edinburgh Artery Study, cases of peripheral arterial disease had higher intakes of alcohol than matched controls, and this difference remained statistically significant after adjusting for age, sex and the levels of nutrients (p = 0.007) .. 103 However, there is some evidence that drinkl.ng alcohol in small quantities is a negative nsk factor for peripheral vascular disease, although when intake reaches more than two units per day it becomes detrimental, an effect which~~y be mediated by alterations in blood pressure, lipid levels and the coagulation system. 104 Other factors which have been implicated as risk factors for the development of cardiovascular disease include an elevated white cell count,105 and a high serum ferritin level. 106 Exercise is. known to improve symptoms of intermittent claudication, possibly by normalizing certain rheological variables.v! but a lack of exercise has not yet been shown to be a risk factor for developing peripheral arterial disease.
Natural history of peripheral arterial disease
There have been numerous reports in the literature concerning the surgical treatment of leg ischaemia, but relatively little about the fate of the majority of patients who do not come to surgery. Some insight into the natural history of peripheral arterial disease, in terms of morbidity and mortality rates, can be obtained from the longitudinal population studies carried out in Framingham,35.107 Basle.P London Whitehall.I'" Denmarks« and Finland,tbut little is known about the natural history of any individual atherosclerotic plaque. Plaque morphology has traditionally been difficult to observe due to the invasive nature of angiography, but future follow-up studies should be possible with the application of new noninvasive imaging techniques such as duplex ultrasound and magnetic resonance imaging.
Morbidity

Secondary to local disease
The degree of morbidity associated with peripheral arterial disease has been determined both by measuring the amputation rate and, more subjectively, by assessing the degree of symptoms. The results of seven follow-up studies of hospital patients with intermittent claudication have been summarized in Table 1 . The duration of follow-up ranges from two and a half to seven years, with approximately 20% experiencing a worsening of symptoms during this period. There is no apP?rent relationship between the number who expenence symptom progression and the duration of followup, although more might have been expected to progress over a longer time period. However, there is some suggestion that deterioration is less in those with nonoperative management, possibly because these subjects had milder disease at the outset. In general, it is thought that the disease will stabilize soon after onset in approximately 75% of patients, and that only about 25~~ill deteriorate significantly.116 However, a subjective improvement in symptoms does not necessarily indicate regression of atherosclerosis, but may simply represent psychological and physiological adaptation to the ischaemia, and the development of a collateral circulation. The amputation rates shown in Table 1 suggest that approximately 7% will have come to amputation after six years although, as expected, the rate is lower in the nonoperative management group. The amputation rates measured in large population-based studies were also much lower, being only 1.6%117 and 1.8%ll8 in patients who developed claudication. In the Basel Study, the five-year cumulative incidence of amputations was as low as 1%.107 Amputation has been shown to be more common if patients are heavy smokers when diagnosed.U? if they continue to smokeu? or are diabetic.P" and less common if subjects have systolic pressures greater than 180 mmHg.121 However, in one study the presence of diabetes or hypertension did not have any effect. 1 10 However, as only 3-22% of those c1audicants presenting to a doctor ever require reconstructive arterial surgery.U" the majority of patients can
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Secondary to generalized disease
In patients presenting with lower limb is~haemia, . the prevalence of coronary artery disease diagnosed by clinical history and electrocardiogram ranges from 19%111 to 47% 122 but in one study using routine angiography the prevalence was as high as 90%. 123 The prevalence of concomitant cerebrovascular disease also varies with the method of detection, but was found to be 52% in one study of 160 patients using Doppler ltrasonography.124In~h.e light of these findings !t~ould be not b~surpnsing for there to be a high incidence of cardiovascular events. Indeed, in the Basel Study after 11 years follow-up, 16% of those with evidence of arterial disease had nonfatal cardiac events, and 12% had cerebrovascular cornplications.Uf In another study looking at an unselected group of claudicants, the incidence at five years was 14% for cardiac events and 5% for cerebrovascular complications. 125
Mortality
The five-year cumulative mortality rates for males with intermittent claudication followed up in cohort studies range from 4.8%108 to 17%,107 are generally higher in men than in women,14.113,126 and increase with increasing age.ll3.114.120.126 However, the relative risk of death in men is similar to that for women.t-" approximately 2.0 after five years and 2.5 after 10 years (Table 2) , and decreases with increasing age. The increased mortality rate is undoubtedly associated with smoking, as smokers have relative risks of between 1.5 and 3.0 compared with nonsmokers, and there is improved survival among subjects who stop smoking.14.119.120,129 Some studies have also shown increased risks associated with hypertension,14.111,l13 elevated serum cholesteroJ14 and diabetes mellitus.P? Therefore subjects with intermittent claudication are likely to die sooner than their healthy counterparts, but very few can actually expect to die from peripheral arterial disease.U! The main cause of death is coronary heart disease, accounting for approximately half of the overall mortality ( Table 2 ). In 7%118 to 17%114 the cause of death will be cerebrovascular disease, and approximately 10% can expect to die from vascular events other than stroke or myocardial ischaemia.tts Follow-up studies have shown that subjects with intermittent claudication have three times the risk of dying from ischaemic heart disease, and twice the risk of dying from stroke as the general population .14,108,130
Conclusions
Peripheral arterial disease is an important cause of morbidity in the general population, especially amongst the elderly. The prevalence increases with age and is higher in males than females, although the sex difference narrows with increasing age. Its distribution throughout the population is similar to that of coronary and cerebrovascular disease, and peripheral arterial disease therefore represents an important indicator of generalized atherosclerosis.
The risk of death in a patient with peripheral arterial disease is two to three times greater than in the general population, but the relative risks are similar in males and females, and decrease with age. However, the risks associated with lower limb atherosclerosis are not primarily due to the disease itself, but to concomitant coronary and cerebrovascular disease. Indeed, up to 50% of patients may expect to die from coronary heart disease, Further longitudinal studies are therefore required to study the coronary and cerebrovascular risks in more detail, particularly in order to identify and target high-risk groups.
General conclusions about the aetiology of peripheral arterial disease may be drawn from cross-sectional surveys, but more conclusive results are required from longitudinal studies. The most important risk factor is probably smoking, and this may also be responsible for the abnormalities in haematocrit, blood viscosity and serum fibrinogen seen in patients with peripheral arterial disease. High blood pressure, especially systolic pressure, may have a significant independent effect, and similarly total and HDL cholesterol both appear to be independent risk factors. Serum triglyceride levels show strong univariate associations with disease in both cross-sectional and case-control studies, but this relationship disappears when correcting for other lipids. There is also conflicting evidence for the role of glucose intolerance as an important risk factor for peripheral arterial disease.
Future results from follow-up studies in Denmark, the USA and Scotland should enable the important risk factors, and their inter-relationships, to be clearly established. The development of more sophisticated methods of assessing peripheral arterial disease noninvasively should open up opportunities for further epidemiological research, and enable accurate estimates of the prevalence of both symptomatic and asymptomatic disease to be obtained.
